News archive - Page 5 of 25

Venture Capital in Biotech: Insights from Giovanni Rizzo (Indaco Venture Partners)

October 23, 2024 By Editorial Staff In Startup, Technologies

In this interview, Giovanni Rizzo, partner at Indaco Venture Partners, shares his insights on the role of venture capital in Italy’s biotech sector. Below is a summary of the key points discussed, broken down into specific questions and timestamp references from the interview. — 1. Why is th...

Zoldasiran and Plozasiran – A New future for Familial Combined Hyperlipidemia

October 03, 2024 By Editorial Staff In Biology

Take Home Message Two newly published manuscripts in the New England Journal of Medicine (N Engl J Med) support the efficacy of reducing triglyceride levels with two new drugs in the treatment of Familial Combined Hyperlipidemia (FCH). These two phase 2 trials, ARCHES-2 and MIUR, separately investig...

Innovations in cortical organoids: accelerating glial development for neurological research.

October 03, 2024 By Editorial Staff In Biology

Take-home message Glia-enriched cortical organoids with mature astrocytes offer a powerful platform to study astrocyte diversity, immune responses, and neurological disorders. This model paves the way for deeper insights into glial biology and disease mechanisms. Background Brain organoids are 3D mo...

EUROPEAN BIOTECH WEEK: ROCHE ITALY OPENS ITS DOORS TO STUDENTS FOR THE 2ND CAREER ORIENTATION OPEN DAY

October 02, 2024 By Editorial Staff In Events

Professionals and university students engage in dialogue to build a bridge between academia and industry, guiding the new generations in choosing their professional paths Monza, October 1, 2024 – For the second year in a row, in celebration of European Biotech Week 2024, Roche Italy opened the doo...

AzurBio Pharma Launches to Fast-Track European Market Entry for Biopharma Companies with Breakthrough Treatments

October 01, 2024 By Editorial Staff In Regulatory

PARIS, France, October 01, 2024 / Biotech Newswire / — AzurBio Pharma, specializing in bringing innovative pharmaceutical products to European markets and focusing on rare and serious diseases with unmet medical needs, is announcing its official launch. AzurBio Pharma is headquartered in Paris...

Omnibus Decree: Reporter’s Amendment Approved to Save Santa Lucia

October 01, 2024 By Editorial Staff In Regulatory

Salvitti (FdI): Continuity Guaranteed. Rocca: Essential Facility (ANSA) – ROME, Sept 29 – The Budget and Finance Committees of the Senate have approved an amendment to the Omnibus Decree by Fratelli d’Italia senator Giorgio Salvitti, aimed at saving the Santa Lucia Foundation. “The proposal ...

1 2 3 4 5 6 7 8 9 10 … 21 22 23 24 25